Several tumor biomarkers can help guide treatment decisions, including Human Epidermal Growth Factor Receptor-2 (HER2), Programmed Cell Death-Ligand 1 (PDL1) and Vascular Endothelial Growth Factor Receptor (VEGFR) [24,25,26]. The gene discussed is KDR; the disease is neoplasm.